In the cerebral cortex, the seizure phenotype of SCN1A may be modified by MYH9, whereas in the bone marrow, MYH9 may have an independent dual molecular effect, leading to thrombocytopenia (Figure 3D). Here, MYH9 is linked to Thrombocytopenia.